Shyam Sundar Selected Research

Immunosorbents

1/2019	Detection of Immunoglobulin G1 Against rK39 Improves Monitoring of Treatment Outcomes in Visceral Leishmaniasis.
2/2011	Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India.
9/2004	Purification, characterization of O-acetylated sialoglycoconjugates-specific IgM, and development of an enzyme-linked immunosorbent assay for diagnosis and follow-up of indian visceral leishmaniasis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shyam Sundar Research Topics

Disease

172	Visceral Leishmaniasis (Kala Azar) 05/2024 - 09/2002
39	Leishmaniasis 05/2024 - 08/2005
38	Infections 12/2023 - 10/2002
7	Neoplasms (Cancer) 10/2020 - 03/2008
5	Inflammation (Inflammations) 02/2024 - 01/2016
5	Parasitic Diseases (Parasitic Disease) 01/2019 - 01/2012
5	Coinfection 01/2019 - 11/2008
5	Body Weight (Weight, Body) 04/2013 - 11/2002
4	Fever (Fevers) 08/2016 - 06/2007
4	Acquired Immunodeficiency Syndrome (AIDS) 08/2016 - 01/2014
3	Cutaneous Leishmaniasis 04/2024 - 12/2002
3	Hemolysis 04/2024 - 04/2004
3	Neglected Diseases 08/2022 - 01/2015
3	Asymptomatic Infections 01/2022 - 06/2012
3	Communicable Diseases (Infectious Diseases) 01/2019 - 01/2013
3	Hypersensitivity (Allergy) 08/2016 - 01/2012
3	Malaria 07/2012 - 02/2008
3	Vomiting 06/2007 - 11/2002
2	Leprosy (Hansen's Disease) 01/2023 - 02/2008
2	Pain (Aches) 07/2020 - 06/2007
2	Papillomavirus Infections 12/2018 - 01/2016
2	Tuberculosis (Tuberculoses) 01/2014 - 02/2008
2	Cardiotoxicity 01/2014 - 12/2010
2	Anemia 01/2011 - 04/2004
2	Diarrhea 01/2004 - 11/2002
1	Parkinson Disease (Parkinson's Disease) 05/2024
1	Multiple Sclerosis 05/2024
1	Wounds and Injuries (Trauma) 04/2024
1	Aneuploidy (Aneuploid) 01/2022

Drug/Important Bio-Agent (IBA)

31	miltefosine (Impavido)IBA 05/2024 - 11/2002
24	AntigensIBA 01/2021 - 08/2005
23	Proteins (Proteins, Gene)FDA Link 02/2024 - 08/2009
21	AntimonyIBA 01/2020 - 12/2002
19	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2023 - 11/2002
19	VaccinesIBA 01/2022 - 12/2006
14	liposomal amphotericin B FDA Link 08/2022 - 12/2002
11	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 11/2021 - 06/2007
10	Interleukin-10 (Interleukin 10)IBA 01/2020 - 04/2007
8	CytokinesIBA 04/2024 - 01/2012
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2008
6	Immunoglobulin G (IgG)IBA 01/2019 - 05/2010
6	EnzymesIBA 01/2019 - 09/2004
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 06/2012
5	Messenger RNA (mRNA)IBA 04/2019 - 04/2007
5	Interleukin-12 (IL 12)IBA 01/2016 - 01/2012
5	deoxycholate drug combination amphotericin BIBA 01/2014 - 02/2004
4	InsecticidesIBA 07/2023 - 08/2008
4	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 06/2017 - 01/2012
4	SodiumIBA 08/2015 - 08/2003
4	gluconic acid (gluconate)FDA LinkGeneric 08/2015 - 08/2003
4	Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA 02/2015 - 06/2005
3	LipidsIBA 04/2024 - 02/2004
3	AntibodiesIBA 01/2023 - 02/2011
3	ChemokinesIBA 01/2021 - 10/2014
3	Imipramine (Janimine)FDA LinkGeneric 01/2020 - 01/2012
3	ImmunosorbentsIBA 01/2019 - 09/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2011
3	Interferon-gamma (Interferon, gamma)IBA 01/2018 - 04/2011
3	ArsenicIBA 03/2015 - 09/2011
3	18S Ribosomal RNAIBA 06/2012 - 10/2010
3	8-aminoquinolineIBA 06/2011 - 12/2002
2	Antiparasitic Agents (Antiparasitics)IBA 12/2023 - 08/2022
2	Lipid NanoparticlesIBA 12/2023 - 01/2020
2	Immunoglobulin M (IgM)IBA 01/2023 - 09/2004
2	ProteomeIBA 01/2022 - 12/2006
2	LigandsIBA 01/2022 - 08/2012
2	AmphiregulinIBA 01/2022 - 01/2022
2	InterferonsIBA 01/2021 - 01/2019
2	ArginaseIBA 01/2020 - 04/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 12/2017
2	CreatinineIBA 09/2019 - 09/2007
2	Peptides (Polypeptides)IBA 01/2019 - 09/2002
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019 - 01/2018
2	tryparedoxin peroxidaseIBA 01/2018 - 04/2015
2	Interleukin-4 (Interleukin 4)IBA 01/2018 - 01/2012
2	trypanothione reductaseIBA 01/2015 - 03/2014
2	Sulfhydryl Compounds (Thiols)IBA 12/2014 - 01/2006
2	EmulsionsIBA 09/2014 - 08/2011
2	Protein Disulfide-IsomerasesIBA 01/2014 - 01/2012
2	Fluconazole (Zonal)FDA LinkGeneric 01/2014 - 12/2002
2	leishmaninIBA 11/2011 - 04/2009
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2007 - 01/2004
1	Apolipoproteins E (ApoE)IBA 05/2024
1	ApolipoproteinsIBA 05/2024
1	Vitamin E FDA LinkGeneric 04/2024
1	Drug CarriersIBA 04/2024
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 04/2024
1	Interleukin-7 (Interleukin 7)IBA 02/2024
1	MelatoninIBA 12/2023
1	febrifugineIBA 05/2022
1	Growth Factor ReceptorsIBA 01/2022

Therapy/Procedure

29	Therapeutics 04/2024 - 12/2002
7	Aftercare (After-Treatment) 02/2021 - 01/2004
6	Drug Therapy (Chemotherapy) 02/2015 - 02/2009
4	Duration of Therapy 01/2018 - 02/2011
3	Immunotherapy 01/2017 - 01/2014
3	Art Therapy 07/2016 - 11/2015
2	Oral Administration 12/2023 - 02/2011
2	Conservative Treatment 09/2011 - 04/2011
2	Injections 06/2007 - 11/2002